Spots Global Cancer Trial Database for testicular neoplasms
Every month we try and update this database with for testicular neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Role of Axumin PET Scan in Germ Cell Tumor | NCT03426865 | Testis Cancer Germ Cell Tumor Testicular Canc... Germ Cell Tumor... Germ Cell Tumor... Testicular Neop... Testicular Germ... Testicular Yolk... Testicular Chor... Testicular Dise... Germ Cell Cance... Germ Cell Neopl... Germ Cell Cance... | Axumin PET scan | 18 Years - | University of Texas Southwestern Medical Center | |
| Engagement of Patients With Advanced Cancer | NCT02966509 | End of Life Advanced Cancer Lung Neoplasm Gastric Cancer Colon Cancer Glioblastoma Mu... Head and Neck N... Rectum Cancer Melanoma Kidney Cancer Prostate Cancer Testicular Neop... Liver Cancer Cancer of Unkno... | EPAC | 18 Years - | Stanford University | |
| Testicular Cancer and Aerobic and Strength Training | NCT02577172 | Testicular Neop... | Exercise group Control group | 18 Years - 60 Years | Oslo University Hospital | |
| Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors | NCT02499952 | Germ Cell Neopl... Testicular Neop... Non Seminomatou... Mediastinal Neo... Genital Neoplas... Genital Neoplas... Ovarian Neoplas... | Pembrolizumab | 18 Years - | Hoosier Cancer Research Network | |
| Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer | NCT02341989 | Testicular Neop... Seminoma | Bleomycin Etopo... Carboplatin | 18 Years - 60 Years | St. Olavs Hospital | |
| Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors | NCT01851200 | Germ Cell Cance... | Brentuximab Ved... | 18 Years - | Fondazione Michelangelo | |
| Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors | NCT02161692 | Testicular Neop... Germ Cell Tumor... | Cyclophosphamid... Etoposide Cisplatin Bleomycin Carboplatin | 18 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Symptoms and Clinical Signs of Hypogonadism in Testicular Cancer Survivors | NCT02240966 | Metabolic Syndr... Hypogonadism Cardio-vascular... | 18 Years - 65 Years | Rigshospitalet, Denmark | ||
| Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer | NCT02341989 | Testicular Neop... Seminoma | Bleomycin Etopo... Carboplatin | 18 Years - 60 Years | St. Olavs Hospital | |
| The Platinum Study Comparison Group | NCT02890030 | Testicular Neop... | Questionnaire | 18 Years - 55 Years | Indiana University | |
| Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy | NCT02492360 | Peripheral Nerv... Testicular Neop... | Blood sample co... Report of perip... | 18 Years - | Indiana University | |
| Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma | NCT00001270 | Breast Neoplasm... Lymphoma Neoplasm Metast... Testicular Neop... | interleukin-1 | - | National Institutes of Health Clinical Center (CC) | |
| High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II | NCT00231582 | Testicular Neop... | epirubicin high-dose and a... paclitaxel etoposide ifosfamide carboplatin | 18 Years - 65 Years | Assistance Publique - Hôpitaux de Paris | |
| A Study of SGN-ALPV in Advanced Solid Tumors | NCT05229900 | Ovarian Neoplas... Endometrial Neo... Carcinoma, Non-... Stomach Neoplas... Gastroesophagea... Uterine Cervica... Testicular Neop... | SGN-ALPV | 18 Years - | Seagen Inc. | |
| Quality of Life Among Testicular Cancer Survivors | NCT02304575 | Testicular Neop... Spermatic Cord ... Varicocele Testicular Hydr... | Questionnaires Hormonal Functi... | 18 Years - 75 Years | Rabin Medical Center | |
| Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours | NCT04122430 | Testicular Neop... | Review of Healt... | - | Walter and Eliza Hall Institute of Medical Research | |
| Lymphedema After Urologic Surgery | NCT05264337 | Urinary Bladder... Prostatic Neopl... Testicular Neop... Penile Cancer | Self-reported l... Dielectric cons... Limb volume | 18 Years - | Vastra Gotaland Region | |
| Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence | NCT00123773 | Sarcoma Multiple Myelom... Testicular Neop... Ovarian Neoplas... Kidney Neoplasm... | Positron Emissi... | 15 Years - | AHS Cancer Control Alberta | |
| Quality of Life Among Testicular Cancer Survivors | NCT02304575 | Testicular Neop... Spermatic Cord ... Varicocele Testicular Hydr... | Questionnaires Hormonal Functi... | 18 Years - 75 Years | Rabin Medical Center | |
| Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors | NCT02161692 | Testicular Neop... Germ Cell Tumor... | Cyclophosphamid... Etoposide Cisplatin Bleomycin Carboplatin | 18 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT) | NCT06309732 | Testicular Neop... | Pegfilgrastim Dactinomycin Methotrexate Etoposide Cisplatin Epirubicin | 16 Years - 35 Years | Queen Mary University of London |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
